What is the ticker symbol for Boundless Bio?

Boundless Bio trades under the ticker BOLD on NASDAQ.

What sector does Boundless Bio operate in?

Boundless Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BOLD in a portfolio?

PortView shows BOLD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Boundless Bio (BOLD) Stock Analysis

NASDAQHealthcareBiotechnology

$2.86-1.04%

1-year price historyRange $1.05 – $3.00

52-week range$2.86

$0.96$3.16

What Boundless Bio does

Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless Bio is advancing BBI-825, another oral inhibitor, this one targeting ribonucleotide reductase (RNR), also in Phase 1/2 clinical development for cancer patients exhibiting resistance gene amplifications. A third initiative, the ecDTx 3 program, is designed to target a kinesin crucial for the cellular segregation mechanism of ecDNA. Incorporated in 2018, the company originally operated as Pretzel Therapeutics, Inc. before adopting the name Boundless Bio, Inc. in July 2019. Its headquarters are situated in San Diego, California.

Key metrics

Market cap

$64.28M

P/E (TTM)

-1.00

EPS (TTM)

$-2.86

Beta

0.38

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$2.65

200-day avg

$1.61

52-week high

$3.16

52-week low

$0.96

CEO

Zachary Hornby

ETFs linked to BOLD

Broad-market and Healthcare sector ETFs an investor holding Boundless Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BOLD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BOLD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Boundless Bio?: Boundless Bio trades under the ticker BOLD on NASDAQ.
Which exchange is BOLD listed on?: BOLD is listed on NASDAQ.
What sector does Boundless Bio operate in?: Boundless Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BOLD in a portfolio?: PortView shows BOLD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.